- Home
- ATNM vs TPIC Comparison
ATNM vs TPIC Comparison
Compare ATNM & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- TPIC
- Stock Information
- Founded
- ATNM 2000
- TPIC 1968
- Country
- ATNM United States
- TPIC United States
- Employees
- ATNM N/A
- TPIC N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- TPIC Industrial Machinery/Components
- Sector
- ATNM Health Care
- TPIC Industrials
- Exchange
- ATNM Nasdaq
- TPIC Nasdaq
- Market Cap
- ATNM 51.5M
- TPIC 35.5M
- IPO Year
- ATNM N/A
- TPIC 2016
- Fundamental
- Price
- ATNM $1.54
- TPIC $1.20
- Analyst Decision
- ATNM Strong Buy
- TPIC Hold
- Analyst Count
- ATNM 3
- TPIC 6
- Target Price
- ATNM $4.67
- TPIC $1.82
- AVG Volume (30 Days)
- ATNM 229.8K
- TPIC 466.0K
- Earning Date
- ATNM 05-09-2025
- TPIC 05-12-2025
- Dividend Yield
- ATNM N/A
- TPIC N/A
- EPS Growth
- ATNM N/A
- TPIC N/A
- EPS
- ATNM N/A
- TPIC N/A
- Revenue
- ATNM N/A
- TPIC $1,373,242,000.00
- Revenue This Year
- ATNM N/A
- TPIC $9.46
- Revenue Next Year
- ATNM N/A
- TPIC $8.03
- P/E Ratio
- ATNM N/A
- TPIC N/A
- Revenue Growth
- ATNM N/A
- TPIC 3.05
- 52 Week Low
- ATNM $1.03
- TPIC $0.64
- 52 Week High
- ATNM $8.64
- TPIC $5.75
- Technical
- Relative Strength Index (RSI)
- ATNM 49.81
- TPIC 58.77
- Support Level
- ATNM $1.56
- TPIC $1.15
- Resistance Level
- ATNM $1.69
- TPIC $1.39
- Average True Range (ATR)
- ATNM 0.11
- TPIC 0.12
- MACD
- ATNM -0.01
- TPIC 0.01
- Stochastic Oscillator
- ATNM 32.18
- TPIC 62.75
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.